Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Febuxostat Tablets 80 mg vs Feburic 80 mg in healthy Thai volunteers under fasting
TCTR20240831005Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of febuxostat in hyperuricemia and gout (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
febuxostat
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on TCTR20240831005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240831005.